TOP1P1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.598400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.886230E-01
Normal-vs-Stage2
4.322600E-01
Normal-vs-Stage3
3.334800E-01
Normal-vs-Stage4
3.735700E-02
Stage1-vs-Stage2
4.966400E-01
Stage1-vs-Stage3
2.930500E-02
Stage1-vs-Stage4
4.014000E-01
Stage2-vs-Stage3
5.369700E-02
Stage2-vs-Stage4
1.846610E-01
Stage3-vs-Stage4
7.820200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.667600E-01
Normal-vs-AfricanAmerican
4.193800E-01
Normal-vs-Asian
8.970400E-01
Caucasian-vs-AfricanAmerican
7.350200E-01
Caucasian-vs-Asian
2.712800E-01
AfricanAmerican-vs-Asian
3.537200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.991400E-01
Normal-vs-Female
5.604600E-01
Male-vs-Female
2.719200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.111400E-01
Normal-vs-Age(41-60Yrs)
1.869030E-01
Normal-vs-Age(61-80Yrs)
6.879200E-01
Normal-vs-Age(81-100Yrs)
4.771000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.766600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.931400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.926600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.776900E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.688800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.595400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.853000E-01
Normal-vs-Daily Drinker
6.745000E-01
Normal-vs-Weekly Drinker
4.396600E-01
Normal-vs-Occasional Drinker
3.262600E-01
Normal-vs-Social Drinker
3.017200E-01
Non Drinker-vs-Daily Drinker
7.137000E-01
Non Drinker-vs-Weekly Drinker
7.788000E-01
Non Drinker-vs-Occasional Drinker
5.693200E-01
Non Drinker-vs-Social Drinker
7.827800E-01
Daily Drinker-vs-Weekly Drinker
5.364800E-01
Daily Drinker-vs-Occasional Drinker
3.438000E-01
Daily Drinker-vs-Social Drinker
5.061400E-01
Weekly Drinker-vs-Occasional Drinker
8.090400E-01
Weekly Drinker-vs-Social Drinker
9.725200E-01
Occasional Drinker-vs-Social Drinker
7.492000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.534600E-01
Normal-vs-Grade 2
8.686800E-01
Normal-vs-Grade 3
7.745000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.234800E-01
Grade 1-vs-Grade 3
2.014200E-02
Grade 1-vs-Grade 4
9.534600E-01
Grade 2-vs-Grade 3
5.032100E-02
Grade 2-vs-Grade 4
8.686800E-01
Grade 3-vs-Grade 4
7.745000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.157400E-01
Normal-vs-NonDiabetic
4.518400E-01
Diabetic-vs-NonDiabetic
8.627900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.678200E-01
Normal-vs-NoPancreatitis
5.250000E-01
Pancreatitis-vs-NoPancreatitis
7.005200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.225400E-01
Normal-vs-N1
4.283800E-01
N0-vs-N1
5.996000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.324600E-01
Normal-vs-TP53-NonMutant
6.706200E-01
TP53-Mutant-vs-TP53-NonMutant
1.275590E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
